Notice of Intent to Sole Source � Bio-Rad Laboratories, Inc.
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH - CC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 26-007652 in this department, oldest first.
- Jul 22, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
The purpose of this procurement is to secure the instrument and reagents for the Bio-Rad CFX Opus 96 Real-Time PCR System to be used at the National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM) � Product Service Code: 6515 � Medical Instruments, Equipment, and Supplies � NAICS Code: 339112 � Surgical and Medical Instrument Manufacturing � Place of Performance: Bethesda, MD 20892 USA POTS: 26-007652 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. Th… (show all)
e National Institutes of Health (NIH) intends to award a fixed price purchase order to Bio-Rad Laboratories, Inc., located at 1000 Alfred Nobel Dr., Hercules, CA, 94547 on a firm fixed price sole source award basis to provide the required instrument and reagents to the National Institutes of Health DLM. Funding for the research to be completed with the patient samples obtained through this contract is from the 2026 Research Award for Staff Clinicians (RASCL) Award to the NIH program. For the initial studies, a local PH center of excellence is required that has an institution affiliation with the IC. Thus, in order to maintain the integrity of the research plan and adhere to the proposed work that received funding, competition will be limited for this project. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 29, 2026 at 4pm EST.
Who won similar work
13 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same NAICS 339112.
Single-winner award sizes (13): middle half $99.0M to $99.0M, median $99.0M; range $71K to $99.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| THE STRONGHOLD GROUP LLC · $PWR · $32.9B | 1 | $99.0M | Dec 6, 2024 |
| DEMETECH CORPORATION | 1 | $99.0M | Dec 6, 2024 |
| NEW YORK EMBROIDERY STUDIO, INC. | 1 | $99.0M | Dec 6, 2024 |
| ATLANTIC TRADING LLC | 1 | $99.0M | Dec 6, 2024 |
| PRESTIGE AMERITECH LTD | 1 | $99.0M | Jan 8, 2025 |
| HISCOMP LLC | 1 | $99.0M | Dec 6, 2024 |
| O&M Halyard, Inc | 1 | $99.0M | Dec 6, 2024 |
| MACLEAN-PANEFFORT, LLC | 1 | $99.0M | Dec 6, 2024 |
| 3M COMPANY | 1 | $99.0M | Dec 6, 2024 |
| USA CAPITAL FUND LLC | 1 | $99.0M | Dec 6, 2024 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $PWR reported $32.9B revenue (12 months to Jun 30, 2026). The median single-winner award in these 13 past awards, $99.0M, is 0.3% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Jun 30, 2026IRADIMED CORPORATION$71K66--Purchase Order for One (1) Dual MRI Infusion SysteMateriality: 0.08% of $IRMD revenue (Low) SEC
- Jan 8, 2025PRESTIGE AMERITECH LTD$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024HISCOMP LLC$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024MACLEAN-PANEFFORT, LLC$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024MERROW MANUFACTURING LLC$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024NEW YORK EMBROIDERY STUDIO, INC.$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024ATLANTIC TRADING LLC$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024THE STRONGHOLD GROUP LLC$99.0MPPE NIH Wide Requirement with potential HHS UseMateriality: 0.30% of $PWR revenue (Low) SEC
- Dec 6, 2024USA CAPITAL FUND LLC$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
- Dec 6, 2024O&M Halyard, Inc$99.0MPPE NIH Wide Requirement with potential HHS UseNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.